Structure-Based Screening of Potential Triterpenoids for Anti-Viral Activity Against SARS-CoV-2 and Related Coronaviruses
Preprints are manuscripts made publicly available before they have been submitted for formal peer review and publication. They might contain new research findings or data. Preprints can be a draft or final version of an author's research but must not have been accepted for publication at the time of submission.
Triterpenoids possess valuable medicinal
properties ranging from anti-microbial to anti-cancer. Some of them were known
for their activity against HIV, Ebola and Influenza viruses. In this study, 108
triterpenoids were screened for its potential usage as anti-viral drug against
SARS-CoV-2, MERS and SARS coronaviruses, using molecular docking calculation
against their main proteases (Mpro) and ADME based drug-likeliness parameters.